Scientific Research An Academic Publisher
OPEN ACCESS
Add your e-mail address to receive free newsletters from SCIRP.
Select Journal AA AAD AAR AASoci AAST ABB ABC ABCR ACES ACS ACT AD ADR AE AER AHS AID AiM AIT AJAC AJC AJCC AJCM AJIBM AJMB AJOR AJPS ALAMT ALC ALS AM AMI AMPC ANP APD APE APM ARS ARSci AS ASM BLR CC CE CellBio ChnStd CM CMB CN CRCM CS CSTA CUS CWEEE Detection EMAE ENG EPE ETSN FMAR FNS GEP GIS GM Graphene GSC Health IB ICA IIM IJAA IJAMSC IJCCE IJCM IJCNS IJG IJIDS IJIS IJMNTA IJMPCERO IJNM IJOC IJOHNS InfraMatics JACEN JAMP JASMI JBBS JBCPR JBiSE JBM JBNB JBPC JCC JCDSA JCPT JCT JDAIP JDM JEAS JECTC JEMAA JEP JFCMV JFRM JGIS JHEPGC JHRSS JIBTVA JILSA JIS JMF JMGBND JMMCE JMP JPEE JQIS JSBS JSEA JSEMAT JSIP JSS JSSM JST JTR JTST JTTs JWARP LCE MC ME MI MME MNSMS MPS MR MRC MRI MSA MSCE NJGC NM NR NS OALib OALibJ ODEM OJA OJAB OJAcct OJAnes OJAP OJApo OJAppS OJAPr OJAS OJBD OJBIPHY OJBM OJC OJCB OJCD OJCE OJCM OJD OJDer OJDM OJE OJEE OJEM OJEMD OJEpi OJER OJF OJFD OJG OJGas OJGen OJI OJIC OJIM OJINM OJL OJM OJMC OJMetal OJMH OJMI OJMIP OJML OJMM OJMN OJMP OJMS OJMSi OJN OJNeph OJO OJOG OJOGas OJOp OJOph OJOPM OJOTS OJPathology OJPC OJPChem OJPed OJPM OJPP OJPS OJPsych OJRA OJRad OJRD OJRM OJS OJSS OJSST OJST OJSTA OJTR OJTS OJU OJVM OPJ POS PP PST PSYCH SAR SCD SGRE SM SN SNL Soft SS TEL TI UOAJ VP WET WJA WJCD WJCMP WJCS WJET WJM WJNS WJNSE WJNST WJV WSN YM
More>>
V. Sridama and L. J. DeGroot, “Treatment of Graves’ Disease and the Course of Ophthalmopathy,” American Journal of Medicine, Vol. 87, No. 1, 1989, pp. 70-73. http://dx.doi.org/10.1016/S0002-9343(89)80485-1
has been cited by the following article:
TITLE: Grave’s Eye Ophthalmopathy Developing Following Radioiodine Therapy for Toxic Adenoma
AUTHORS: Hala Chafic Ahmadieh, Ibrahim Salti
KEYWORDS: Grave’s Ophthalmopathy; Toxic Adenoma; Toxic Nodular Goiter; Radioiodine Therapy
JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.3 No.6, October 24, 2013
ABSTRACT: The development of Grave’s ophthalmopathy following radioiodine treatment for Grave’s disease is well recognized. However, development of Grave’s ophthalmopathy following radioiodine therapy given for toxic adenoma or toxic nodular goiter has been reported but very rarely. Hereby, we reported a case of a 69-year-old male patient who developed ophthalmopathy after receiving 30 mCi (1110 mBq) 131 I radioiodine treatment for a toxic nodule. In addition, a review of the current literature with regards to this topic is presented.
Related Articles:
Pathophysiology of Graves’ Ophthalmopathy: A Literature Review
Mariela Carolina Santos Carballo, Bianca Paiva Cunha de Sá, Denise Rosso Tenório Wanderley Rocha, Alberto Krayyem Arbex
DOI: 10.4236/ojemd.2017.71008 1,607 Downloads 3,295 Views Citations
Pub. Date: January 17, 2017
Erratum to “The Faraday Isolator, Detailed Balance and the Second Law” [Journal of Applied Mathematics and Physics, Vol. 5, No. 4, April 2017 PP. 889-899]
George S. Levy
DOI: 10.4236/jamp.2017.58127 1,468 Downloads 2,850 Views Citations
Pub. Date: August 25, 2017
Comment on the Paper “Condom-Assisted Transurethral Resection: A New Surgical Technique for Urethral Tumor”, Surgical Science, Vol. 1, 2010, pp. 46-48
Guven Aslan
DOI: 10.4236/ss.2011.24042 4,555 Downloads 7,579 Views Citations
Pub. Date: June 23, 2011
Erratum to “Simple Method for Evaluating Singular Integrals” [American Journal of Computational Mathematics, Volume 7, Number 4, December 2017 PP. 444-450]
Nhan T. Tran
DOI: 10.4236/ajcm.2019.93015 397 Downloads 712 Views Citations
Pub. Date: September 27, 2019
Effect of Intravenous Methylprednisolone on the Signs & Symptoms of Graves’ Ophthalmopathy
Muhammad Shah Alam, A. B. M. Kamrul-Hasan, Syeda Tanzina Kalam, Ajit Kumar Paul, Shahjada Selim
DOI: 10.4236/ojemd.2019.99010 350 Downloads 568 Views Citations
Pub. Date: September 30, 2019
